Microchip shares slide pre-market as BofA cuts rating to 'underperform'

Microchip Technology's stock dropped over 3% due to a downgrade by BofA Securities, citing weak recovery, high valuation, and excess inventory concerns amid industry challenges.

'In AI we trust': Bank of America highlights 6 key chip stocks to own for 2025

Bank of America forecasts a 15% increase in semiconductor sales for 2025, recommending six stocks, including NVIDIA and Broadcom, while suggesting market shifts and rating changes.

Microchip Tech halts application for $162 mln CHIPS grant- Bloomberg

Microchip Technology pauses its CHIPS Act funding application after cutting its revenue forecast and announcing an Arizona factory closure, affecting 500 jobs amid inventory challenges.

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.17%

U.S. stocks were mixed with notable gains in tech and telecom sectors, while declines were seen in consumer goods and financials. Key stocks reached all-time highs.

After-hours movers: Zscaler, Honeywell, Microchip Technology and more

Zscaler and others fell in after-hours trading, while Credo Technology and Janux Therapeutics saw gains due to strong guidance and positive clinical data, respectively.

Microchip Technology revises revenue outlook, plans fab closure; shares drop

5 big analyst AI moves: Any Nvidia stock pullback is ‘an opportunity’

Analysts provide insights on major AI stocks, highlighting cautious investor sentiment toward Microsoft, opportunities in Nvidia, renewed interest in Tesla, Dell's growth in AI servers, and a potential semiconductor recovery.

Earnings call: Microchip Technology navigates market headwinds in Q2 FY2025

After-hours movers: Super Micro Computer, Exact Sciences, Trump Media & Technology

Super Micro, Exact Sciences, Coupang, Microchip Technology, Lumen Technologies, and Trump Media stocks showed significant after-hours movements based on quarterly results and forecasts.

Microchip earnings beat by $0.03, revenue topped estimates

Microchip exceeded EPS and revenue estimates in Q2 but lowered guidance for Q3 2025, with stock prices showing slight declines over the past year.